Your browser doesn't support javascript.
loading
A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires.
Costedoat-Chalumeau, Nathalie; Houssiau, Frédéric; Izmirly, Peter; Le Guern, Véronique; Navarra, Sandra; Jolly, Meenakshi; Ruiz-Irastorza, Guillermo; Baron, Gabriel; Hachulla, Eric; Agmon-Levin, Nancy; Shoenfeld, Yehuda; Dall'Ara, Francesca; Buyon, Jill; Deligny, Christophe; Cervera, Ricard; Lazaro, Estibaliz; Bezanahary, Holy; Leroux, Gaëlle; Morel, Nathalie; Viallard, Jean-François; Pineau, Christian; Galicier, Lionel; Van Vollenhoven, Ronald; Tincani, Angela; Nguyen, Hanh; Gondran, Guillaume; Zahr, Noel; Pouchot, Jacques; Piette, Jean-Charles; Petri, Michelle; Isenberg, David.
Afiliación
  • Costedoat-Chalumeau N; AP-HP, Cochin Hospital, Internal Medicine Department, Centre de référence maladies auto-immunes et systémiques rares, Paris, France; Université Paris Descartes-Sorbonne Paris Cité, Paris, France; INSERM U 1153, Center for Epidemiology and Statistics Sorbonne Paris Cité (CRESS), Paris, France.
  • Houssiau F; Service de Rhumatologie, Cliniques Universitaires Saint-Luc; Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Université catholique de Louvain, Brussels, Belgium.
  • Izmirly P; Division of Rheumatology, Department of Medicine, New York University School of Medicine, New York, USA.
  • Le Guern V; AP-HP, Cochin Hospital, Internal Medicine Department, Centre de référence maladies auto-immunes et systémiques rares, Paris, France; Université Paris Descartes-Sorbonne Paris Cité, Paris, France; INSERM U 1153, Center for Epidemiology and Statistics Sorbonne Paris Cité (CRESS), Paris, France.
  • Navarra S; University of Santo Tomas Hospital, Manila, Philippines.
  • Jolly M; Rush University Medical Center, Rush Lupus Clinic, Chicago, Illinois, USA.
  • Ruiz-Irastorza G; Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain.
  • Baron G; AP-HP, Hôpital Hôtel-Dieu, Centre d'Epidémiologie Clinique, Paris, Université Paris Descartes-Sorbonne Paris Cité, Paris, France.
  • Hachulla E; Claude Huriez Hospital, Internal Medicine Department, Centre de Référence Maladies Auto-immunes et Systémiques rares, Université de Lille, Lille, France.
  • Agmon-Levin N; Sheba Medical Center, Zabludowicz Center for Autoimmune Diseases, Tel-Hashomer, Israel.
  • Shoenfeld Y; Sheba Medical Center, Zabludowicz Center for Autoimmune Diseases, Tel-Hashomer, Israel.
  • Dall'Ara F; Rheumatology and Clinical Immunology Unit, Spedali Civili and Dept. of Clinical and Experimental Science-University of Brescia, Italy.
  • Buyon J; Division of Rheumatology, Department of Medicine, New York University School of Medicine, New York, USA.
  • Deligny C; Pierre-Zobda-Quitman Hospital, Internal Medicine Department, Martinique, France.
  • Cervera R; Hospital Clínic de Barcelona, Department of Autoimmune Diseases, Barcelona, Spain.
  • Lazaro E; Haut Lévêque Hospital, Internal Medicine Department, Pessac, France.
  • Bezanahary H; Dupuytren Hospital, Internal Medicine Department, Limoges, France.
  • Leroux G; AP-HP, Pitié-Salpêtrière Hospital, Internal Medicine Department, Université Pierre et Marie Curie, Paris, France.
  • Morel N; AP-HP, Cochin Hospital, Internal Medicine Department, Centre de référence maladies auto-immunes et systémiques rares, Paris, France; Université Paris Descartes-Sorbonne Paris Cité, Paris, France; INSERM U 1153, Center for Epidemiology and Statistics Sorbonne Paris Cité (CRESS), Paris, France.
  • Viallard JF; Haut Lévêque Hospital, Internal Medicine Department, Pessac, France.
  • Pineau C; Montreal General Hospital, Lupus Clinic, Montreal, Canada.
  • Galicier L; AP-HP, St Louis Hospital, Clinical Immunology Department, Paris, France.
  • Van Vollenhoven R; Karolinska University Hospital, Department of Medicine, Unit for Clinical Research Therapy, Inflammatory Diseases, Stockholm, Sweden.
  • Tincani A; Rheumatology and Clinical Immunology Unit, Spedali Civili and Dept. of Clinical and Experimental Science-University of Brescia, Italy.
  • Nguyen H; University College London, Centre for Rheumatology, London, UK.
  • Gondran G; Dupuytren Hospital, Internal Medicine Department, Limoges, France.
  • Zahr N; AP-HP, Hopital Pitié-Salpêtrière, Pharmacology Department, Paris, France.
  • Pouchot J; European Georges Pompidou Hospital, Internal Medicine Department, Paris, France.
  • Piette JC; AP-HP, Pitié-Salpêtrière Hospital, Internal Medicine Department, Université Pierre et Marie Curie, Paris, France.
  • Petri M; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Isenberg D; University College London, Centre for Rheumatology, London, UK.
Clin Pharmacol Ther ; 103(6): 1074-1082, 2018 06.
Article en En | MEDLINE | ID: mdl-28925027
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Clin Pharmacol Ther Año: 2018 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Clin Pharmacol Ther Año: 2018 Tipo del documento: Article País de afiliación: Francia